Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
News-Medical.Net on MSN
ICSA 2025: Infection's role in cellular senescence, inflammation, and aging
A new meeting report was published in Volume 17, Issue 12 of Aging-US on December 23, 2025, titled "Cellular senescence meets ...
2don MSN
How are vaccines made?
Measles and smallpox, for example, are viruses; Streptococcus pneumoniae is a bacterium that causes a range of diseases, ...
Researchers have identified a previously unknown giant virus that may offer new insight into how complex life first evolved.
Ionis Pharmaceuticals, Inc. partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results